As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...

March 16, 2011 (Vienna, Austria) — Nearly three-quarters of healthy individuals report that they would consent to being prescribed a placebo medication if they experienced depression, according ...

Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of ...

Dr. Ma discussed key findings that have been shared so far this year on the topic of evolving treatment strategies for ...

SAN FRANCISCO -- Crinecerfont (Crenessity) may help improve metabolic profiles of adults and children with classic congenital ...

The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...

Setmelanotide was associated with significant weight reduction among patients aged 4 years and older with acquired ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

In the first placebo-controlled study of vaporized cannabis for acute migraine, patients report greater relief from pain and ...

Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis ...

Treatment includes intranasal glucocorticoids, which have limited effect on nasal polyp size and symptoms. 12 Patients with severe recurring chronic rhinosinusitis with nasal polyps may undergo ...